If you’re at the Annual Meeting of the AACR (American Association for Cancer Research), come visit our team in person, get some hands-on help, and see the latest developments in how our cloud-based Machine Learning analysis platform can help accelerate more detailed discovery. Meet us at Booth #3603.
Posters and Talks:
We’re excited to see the breadth and depth of presentations throughout the conference program that include work done on the Cytobank platform. In addition to our very own team’s presentation on rapid RNA-seq biomarker discovery, many others have used of Cytobank in their discoveries. See here for a sampling of posters and talks submitted to us by our users. More »
We’re excited to announce a new collaboration with Cytek, makers of the innovative CytekTM Aurora Flow Cytometer. Cytek’s Aurora and Cytobank’s next-generation analytics platform have united in their goal to make high-dimensional data and its subsequent machine learning analysis more accessible to more scientists.
Aurora’s unique optical design combined with spectral unmixing delivers quality, high-dimensional data where rare and dim populations can be easily resolved, regardless of sample complexity.
Cytobank’s algorithms simplify visualization and analysis of high-dimensional unmixed data and allow you to quickly share discrete insights from these data.
Here are two specific examples of how you can apply our combined solutions to enable faster, more highly-resolved discoveries: More »
We were excited to attend the American Society of Hematology meeting this month in Atlanta. Despite the conference beginning with the arrival of an unexpected winter storm, many leading scientists and clinicians congregated to present and discuss cutting-edge research in hematology.
The Cytobank platform was used by many who attended and presented and we were proud to contribute to these scientific advances. Highlights for us were:
Next Generation Sequencing (NGS) and its application in the clinic today was widely discussed. Similar to high dimensional cytometry analyses, developing reproducible and efficient bioinformatics analysis pipelines was identified as a major challenge to dissecting the large volume of data generated by NGS. During the late breaking abstract session, Dr. Tim Grob, presented data from a large prospective clinical trial demonstrating that NGS MRD detection can predict relapse and survival in newly diagnosed AML.Challenges for clinical use of Whole Exome Sequencing presented by Dr. Haferlach.
Cytobank in action: Numerous posters and presentations used Cytobank to investigate immune system response to cancer, dysplasia, and other blood disorders. Some examples include:
Dr. Kat Drake, our Director of Informatics just got back from the annual meeting of the Society for Immunotherapy of Cancer (SITC). Read more for her observations, notes and key takeaways from the world’s foremost conference on Cancer Immunotherapy. More »